Advertisement

Topics

Auris Med Completes Enrollment Of Phase III Healos Trial Of Am-111 For The Treatment Of Sudden Deafness

20:00 EDT 4 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Auris Med Completes Enrollment Of Phase III Healos Trial Of Am-111 For The Treatment Of Sudden Deafness

NEXT ARTICLE

More From BioPortfolio on "Auris Med Completes Enrollment Of Phase III Healos Trial Of Am-111 For The Treatment Of Sudden Deafness"

Advertisement
Quick Search
Advertisement
Advertisement